Big Science Bussines Forum 2022, it is a business-oriented congress that brings together the main European Research Infrastructures, focused on technology and with the aim of being the main meeting point between Research Infrastructures and industry. The Granada Congress Center has been for 4 days -October 4 to 6- the venue for the second edition of the BSBF 2022. Thew event has brought together around 1,200 participants, representatives of more than 500 organizations and almost 30 countries. The initial objective of bringing together institutions, research centers and the science industry to discuss the future perspectives of the Big Science Market and pool synergies was clearly achieved.

Likewise, during the event the business opportunities that, in the coming years, the sector will have in the different business areas and technologies were discussed: particle accelerators, synchrotrons, aerospace, energy, among others. The exhaustive program covered the most relevant topics in the sector: Women in Science, Technology Transfer Track, SME Tracks (small and medium-sized companies), Sustainability. During the three days, all these topics of special interest were exposed in plenary sessions, parallel sessions, satellite meetings, B2B meetings, in which both speakers and attendees were able to discuss the future and the opportunities of the Big Science sector.

ESS Bilbao as an ABSO’s institution (Affiliated Big Science Organizations) had a significant participation in BSBF2022: corporate stand, Mario’s presentation, various BTB meetings. The General Secretaries of Research, Raquel Yotti, and the Secretary of Innovation, Teresa Riesgo, visited our stand where we had the opportunity to talk about the latest advances in our project.

During the closing of the BSBF 2022, it was emphasized that it is an event where infrastructures and industry feel that they are a community with common goals of benefit to society such as, Women in Big Science, Technology transfer track; Sustainable procurement and Career opportunities and pathways in the Big Science market